Anatara Lifesciences announced the appointment of Mr. Simon Erskine as Chief Development Officer and Mr. Michael Pryor as Head of Business Development & Marketing Communications, to progress the Company's commercialisation activities in the gastrointestinal health space. Chief Development Officer ­ Simon Erskine. Mr. Erskine joined Anatara with more than ten years' experience working within the biotechnology, IVD (in vitro diagnostic) medical devices and molecular diagnostics industries. He has held numerous research and development roles including product and clinical development, regulatory affairs and quality assurance, and has successfully translated early-stage research into commercial products for the Australian, European, Canadian and US markets. Head of Business Development & Marketing Communications ­ Michael Pryor. Mr. Pryor is a marketing executive with 20 years' experience in the Australian pharmaceutical industry across marketing, sales and key account management. His experience spans the channels of pharmacy, optometry and grocery, where he has held various sales and marketing roles with multinational companies.